Clinical trial results
Clinical trial
results
Research Sponsor: AstraZeneca
Drugs Studied: AZD8871
National Clinical Trial #: NCT02573155
Protocol #: D6640C00001
Study Date: October 2015 to August 2016
Short Study Title: A study in participants to investigate AZD8871 for
the treatment of chronic obstructive pulmonary
disease and possibly other lung diseases like asthma
Thank you!
As a clinical study participant, you belong to a large community of participants around the world.
You help researchers answer important health questions and discover new medical treatments.
Thank you for taking part in this clinical study for the drug AZD8871. This drug is being developed
to treat chronic obstructive pulmonary disease, also called COPD, and possibly other lung
diseases like asthma. You and all of the other participants helped researchers learn how AZD8871
affects the body, how AZD8871 acts in the body, and if AZD8871 causes medical problems.
AstraZeneca, the sponsor of this study, thanks you for your help and thinks it is important
for you to know the results of your study. An independent non-profit organisation called
CISCRP prepared this summary of the study results for you with the help of a medical writing
organisation. We hope it helps you understand and feel proud of your important role in medical
research. If you have questions about the results, please speak with the study doctors or clinical
staff at your study site.
UK 1